Health and Healthcare
More Problems With Heparin, More Problems For Baxter (BAX)?
Published:
Baxter (NYSE: BAX) is probably retaining more lawyers. So far nineteen people have died from tainted Heparin, a blood-thinner. BAX is one of the largest marketers of the drug.
According to The Wall Street Journal, France, Italy and Denmark recalled the drug yesterday. The trouble is more wide-spread than previously thought.
The ingredients which cause the health problems appear to be made in China.
The question is why Baxter did not have closer look at a medicine used in heart surgery and dialysis.
Douglas A. McIntyre
If you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
Click here to download your FREE copy.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.